Bacoside A + B
Latest Information Update: 06 Aug 2007
At a glance
- Originator Central Drug Research Institute
- Developer Central Drug Research Institute; Velvette International
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 06 Aug 2007 Discontinued - Phase-II for Cognition disorders in India (unspecified route)
- 13 Sep 2000 No-Development-Reported for Cognition disorders in India (Unknown route)
- 13 Jun 1995 Phase-II clinical trials for Cognition disorders in India (Unknown route)